Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study.

Diabetes Metab Syndr · 2022 · PMC8816907 · PMID 35150961

Europe PMC DOI

hedged sentence

0.0490

closest p · 1.0× alpha

0.0490

boldest claim

The sentences

nominally significantp = 0.049actually significant

For the participants with past history of COVID-19, there was a nominally significant increase in GMT at 21-days after second dose (p = 0.049) compared to 21-days after first dose (baseline value), and no significant difference noted compared to baseline value at 3-months (p = 0.26) and 6-months (p = 0.15) after the second dose.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.